Offloading Devices Market Report 2026

The offloading devices market size has grown strongly in recent years. It will grow from $7.32 billion in 2025 to $7.81 billion in 2026 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to rise in diabetic foot ulcers, growth of aging population, increase in podiatric care, expansion of orthopedic device use, higher post surgical recovery needs.

The offloading devices market size is expected to see strong growth in the next few years. It will grow to $10.2 billion in 2030 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to growth in diabetes prevalence, rising home care treatment, expansion of preventive wound care, demand for custom orthotics, increase in outpatient recovery devices. Major trends in the forecast period include custom molded offloading footwear, advanced pressure redistribution insoles, lightweight composite offloading boots, 3d printed orthotic devices, modular removable cast walkers.

The increasing prevalence of diabetes is anticipated to drive the expansion of the offloading devices market in the coming years. Diabetes is a chronic condition that impacts the body's ability to convert food into energy, resulting in elevated blood sugar levels that can lead to serious complications. The rise in diabetes cases is mainly attributed to growing obesity rates, as excess body fat contributes to insulin resistance and higher blood sugar levels. Offloading devices assist diabetes patients by alleviating pressure on vulnerable areas, preventing foot ulcers, promoting quicker wound healing, and lowering the risk of severe complications such as infections or amputations, thereby enhancing mobility, quality of life, and overall outcomes in diabetic care. For example, in June 2024, the National Health Service, a UK government body, reported that 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes in 2023, representing an 18% increase from 3,065,825 cases in 2022. Consequently, the rising prevalence of diabetes is propelling the growth of the offloading devices market.

Leading companies operating in the offloading devices market are prioritizing next-generation external fixation platforms to enhance wound protection, enable precise pressure redistribution, and streamline limb salvage procedures. External fixation platforms are orthopedic support systems that stabilize bones and joints using structures positioned outside the body, often connected to the skeleton through pins or wires. They are commonly used in fracture management, limb reconstruction, and post-surgical recovery. For example, in January 2026, BlueOcean Global, a US-based medical device firm, announced FDA 510(k) clearance for Excelsior, a compact, surgeon-deployable platform for limb salvage in high-risk patients. This system allows clinicians to securely integrate offloading rings and bars into existing fixation setups using standard components, addressing diabetes-related ulcers, infections, trauma, and non-healing wounds in underserved clinical areas such as Charcot reconstruction. These modular frames offload soft tissues from core skeletal loads, enhance stability in complex cases, and are managed through BlueOcean’s proprietary FAST protocols to ensure optimal healing and seamless patient outcomes.

In March 2025, Recovery Force Health, a US-based medical technology company, acquired NelDerm’s HeelP.O.D. product for an undisclosed amount. Through this acquisition, Recovery Force Health seeks to reinforce its leadership in hospital-acquired pressure injury prevention by broadening its pressure offloading portfolio and targeting high-risk anatomical areas with complementary, clinically effective solutions. NelDerm is a US-based provider of specialized pressure offloading devices, focusing on heel ulcer prevention and enhancing clinical access during wound care.

Major companies operating in the offloading devices market are Medline Industries LP, Stryker Corporation, Ottobock SE & Co KGaA, Arjo Group, Invacare Corporation, Guldmann A/S, Etac AB, Permobil AB, Sunrise Medical LLC, Frontier Medical Group, Drive DeVilbiss Healthcare, Joerns Healthcare LLC, AliMed Inc, Seneca Devices Inc., DARCO International Inc., HoverTech International, Beechfield Healthcare Ltd, Next Health LLC, Jewell Nursing Solutions, and Posey Products LLC.

Tariffs on medical device materials, specialty polymers, and orthopedic components are increasing manufacturing costs in the offloading devices market. Product segments such as custom orthotics, offloading boots, and advanced insoles that rely on imported materials are most affected. Import dependent regions face higher device prices and distributor margins. These added costs can influence purchasing decisions in smaller clinics and home care settings. At the same time, tariffs are encouraging local production of orthopedic and pressure relief devices, improving regional supply resilience.

The offloading devices market research report is one of a series of new reports that provides offloading devices market statistics, including offloading devices industry global market size, regional shares, competitors with a offloading devices market share, detailed offloading devices market segments, market trends and opportunities, and any further data you may need to thrive in the offloading devices industry. This offloading devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Offloading devices are medical or assistive devices designed to reduce, redistribute, or relieve pressure from specific body areas, especially feet, joints, or limbs, to promote healing and prevent further injury. They are commonly used for conditions like diabetic foot ulcers, pressure sores, musculoskeletal injuries, and post-surgical recovery to minimize mechanical stress and improve patient comfort.

The principal components of offloading devices include nonremovable knee-high offloading devices, removable knee-high offloading devices, air-assisted lateral transfer systems, replacement sliding sheets, and wheelchairs. Nonremovable knee-high offloading devices are designed to redistribute pressure on the lower limbs and prevent or treat foot ulcers, particularly in patients with limited mobility. These devices are made from materials such as foam, plastics, rubber, composite materials, and advanced polymers, and are used for applications including diabetic foot ulcer management, pressure ulcer prevention and treatment, surgical recovery, post-operative care, diagnostics, and long-term rehabilitation. End users include hospitals, ambulatory surgery centers, nursing homes, long-term care facilities, and home care settings.

The offloading devices market consists of sales of offloading footwear, offloading shoes, offloading boots, cast walkers, total contact casts, removable walking casts, orthopedic insoles, pressure relief insoles, and custom foot orthotics. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.